Actuate Therapeutics Files 8-K for Material Agreement
Ticker: ACTU · Form: 8-K · Filed: Mar 28, 2025 · CIK: 1652935
| Field | Detail |
|---|---|
| Company | Actuate Therapeutics, Inc. (ACTU) |
| Form Type | 8-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-filing
Related Tickers: ACTU
TL;DR
Actuate Therapeutics (ACTU) filed an 8-K today for a material definitive agreement and unregistered equity sales.
AI Summary
Actuate Therapeutics, Inc. filed an 8-K on March 27, 2025, reporting the entry into a material definitive agreement and unregistered sales of equity securities. The company, formerly known as Apotheca Therapeutics, Inc., is incorporated in Delaware and based in Fort Worth, Texas.
Why It Matters
This filing indicates significant corporate activity, potentially involving new partnerships or financing, which could impact the company's future operations and stock value.
Risk Assessment
Risk Level: medium — Filings related to material definitive agreements and unregistered equity sales can introduce uncertainty and potential dilution, requiring further investigation.
Key Players & Entities
- Actuate Therapeutics, Inc. (company) — Registrant
- Apotheca Therapeutics, Inc. (company) — Former company name
- March 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Fort Worth, Texas (location) — Principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Actuate Therapeutics?
The filing does not specify the details of the material definitive agreement, only that one was entered into on or before March 27, 2025.
What type of equity securities were sold in the unregistered sale?
The filing mentions unregistered sales of equity securities but does not provide specific details about the type or amount of securities sold.
When did Actuate Therapeutics change its name from Apotheca Therapeutics, Inc.?
The date of the name change from Apotheca Therapeutics, Inc. to Actuate Therapeutics, Inc. was September 11, 2015.
What is Actuate Therapeutics' Standard Industrial Classification (SIC) code?
Actuate Therapeutics, Inc. has a Standard Industrial Classification (SIC) code of 2834, which corresponds to Pharmaceutical Preparations.
Where are Actuate Therapeutics' principal executive offices located?
Actuate Therapeutics, Inc.'s principal executive offices are located at 1751 River Run, Suite 400, Fort Worth, Texas 76107.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding ACTUATE THERAPEUTICS, INC. (ACTU).